Industry Focus

Can Amarin Corp Plc convert promise into profit? Motley Fool healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the challenges ahead for this volatile biotech stock.

Direct download: 150325_IF_Healthcare.mp3
Category:Podcast -- posted at: 5:15pm EST